Clinical Trial Update: Emgality for Migraine in Breastmilk

View source ↗

Summary

This clinical trial update indicates that a study evaluating galcanezumab (Emgality) for migraine in breastfeeding is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Emgality (galcanezumab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Migraine | Status: RECRUITING